✦ LIBER ✦

A randomised study to compare the efficacy, tolerability and safety between Memantine and Donepezil in moderate to severe Alzheimer's disease

✍ Scribed by Haridas, Kiran M.

Book ID: 122984838
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 41 KB
Volume: 5
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2009.04.516

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolerability of switching from donepezil

Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease

✍ Gunhild Waldemar; Maritta Hyvärinen; Mette Krog Josiassen; Alex Kørner; Heikki L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving

Safety and tolerability of once-daily ve

Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease

✍ Roy W. Jones; Antony Bayer; Fraser Inglis; Andrew Barker; Ravinder Phul 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## Abstract ## Objective To assess the safety and tolerability of three different dosing schedules of memantine in patients with moderate to severe Alzheimer's disease (AD). ## Method This 12‐week, randomised, double‐blind study, investigated three dosing schedules of memantine: OD1 (20 mg once

Long-term safety and tolerability of don

Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease

✍ Pierre Tariot, Steven Salloway, Jane Yardley, Joan Mackell, Margaret Moline 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 197 KB

Efficacy and Safety of Donepezil 23 mg v

Efficacy and Safety of Donepezil 23 mg versus Donepezil 10 mg for Moderate-to-Severe Alzheimers Disease: A Subgroup Analysis in Patients Already Taking or Not Taking Concomitant Memantine

✍ Doody, Rachelle S.; Geldmacher, David S.; Farlow, Martin R.; Sun, Yijun; Moline, 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 458 KB

Long-term safety and efficacy of memanti

Long-term safety and efficacy of memantine treatment in moderate to severe Alzheimer’s disease: Results from a three-year trial

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB

A Meta-Analysis of the Efficacy of Donep

A Meta-Analysis of the Efficacy of Donepezil, Rivastigmine, Galantamine, and Memantine in Relation to Severity of Alzheimer's Disease

✍ Di Santo, Simona Gabriella ;Prinelli, Federica ;Adorni, Fulvio ;Caltagirone, Car 📂 Article 📅 2013 🏛 IOS Press 🌐 English ⚖ 373 KB